We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-3.68%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$982M
AUM Growth
+$92.9M
Cap. Flow
+$134M
Cap. Flow %
13.65%
Top 10 Hldgs %
4.69%
Holding
1,940
New
653
Increased
414
Reduced
285
Closed
576

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$4.61M
2
DPZ icon
Domino's
DPZ
+$3.96M
3
BRKR icon
Bruker
BRKR
+$3.65M
4
TJX icon
TJX Companies
TJX
+$3.62M
5
SBUX icon
Starbucks
SBUX
+$3.58M

Sector Composition

Rank Sector Weight
1 Healthcare 17.3%
2 Industrials 16.2%
3 Technology 12.7%
4 Financials 11.7%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DPZ icon
1176
Domino's
DPZ
$11.6B
$227K 0.02%
476
-7,828
-94% -$3.96M
WT icon
1177
WisdomTree
WT
$3.22B
$226K 0.02%
39,825
+26,860
+207% +$165K
WB icon
1178
Weibo
WB
$1.95B
$225K 0.02%
+4,746
New +$256K
CMTL icon
1179
Comtech Telecommunications
CMTL
$51.8M
$224K 0.02%
8,739
-5,696
-39% -$143K
DBD
1180
DELISTED
Diebold Nixdorf Incorporated
DBD
$224K 0.02%
+22,205
New +$244K
HVT icon
1181
Haverty Furniture Companies
HVT
$454M
$223K 0.02%
6,624
-4,334
-40% -$161K
PIPR icon
1182
Piper Sandler
PIPR
$5.29B
$223K 0.02%
+6,432
New +$215K
XM
1183
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
$223K 0.02%
5,215
-3,512
-40% -$149K
OMCL icon
1184
Omnicell
OMCL
$1.68B
$222K 0.02%
+1,494
New +$229K
ATXS
1185
DELISTED
Astria Therapeutics
ATXS
$221K 0.02%
+24,996
New +$239K
SCCO icon
1186
Southern Copper
SCCO
$166B
$221K 0.02%
4,238
-1,559
-27% -$90.3K
ZBRA icon
1187
Zebra Technologies
ZBRA
$17.8B
$221K 0.02%
+428
New +$239K
UAMY icon
1188
United States Antimony
UAMY
$1.02B
$220K 0.02%
+243,099
New +$224K
LTHM
1189
DELISTED
Livent Corporation
LTHM
$220K 0.02%
+9,508
New +$213K
RTL
1190
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
$220K 0.02%
+27,367
New +$231K
MYRG icon
1191
MYR Group
MYRG
$5.25B
$219K 0.02%
2,206
-8,626
-80% -$848K
PASG icon
1192
Passage Bio
PASG
$14.1M
$219K 0.02%
+1,099
New +$262K
NUVA
1193
DELISTED
NuVasive, Inc.
NUVA
$219K 0.02%
+3,656
New +$225K
CL icon
1194
Colgate-Palmolive
CL
$74.4B
$218K 0.02%
2,882
-536
-16% -$42.6K
DHIL
1195
DELISTED
Diamond Hill
DHIL
$218K 0.02%
+1,240
New +$217K
TXMD icon
1196
TherapeuticsMD
TXMD
$24M
$218K 0.02%
5,870
-673
-10% -$29.9K
AVEO
1197
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$218K 0.02%
+35,232
New +$211K
AMPY icon
1198
Amplify Energy
AMPY
$166M
$217K 0.02%
+40,802
New +$153K
MLI icon
1199
Mueller Industries
MLI
$15.2B
$217K 0.02%
+21,080
New +$225K
PAGP icon
1200
Plains GP Holdings
PAGP
$4.9B
$217K 0.02%
20,178
-159,699
-89% -$1.67M

Similar funds

GSA Capital Partners's Q3 2021 Portfolio in Review

As of Q3 2021, GSA Capital Partners held 1,940 positions worth $982M, up 10% from $889M the previous quarter. Its ten largest holdings account for 4.7% of the portfolio.

GSA Capital Partners deployed $134M of net new capital in Q3 2021, opening 653 new positions and adding to 414 existing holdings. Its largest new stake was Openlane: 280,405 shares worth $4.6M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Amazon, an estimated $4.61M trimmed.

  • GSA Capital Partners's largest Q3 2021 buy was Openlane: 280,405 shares worth $4.6M.
  • GSA Capital Partners added most to BridgeBio Pharma in Q3 2021, an estimated $4.54M increase.
  • GSA Capital Partners's biggest Q3 2021 reduction was Amazon, cutting an estimated $4.61M.
  • GSA Capital Partners fully exited TJX Companies in Q3 2021, selling an estimated $3.62M.
  • GSA Capital Partners's ten largest holdings make up 4.7% of its $982M portfolio in Q3 2021.
  • GSA Capital Partners opened 653 new positions and closed 576 in Q3 2021.
  • GSA Capital Partners's portfolio value rose 10% quarter-over-quarter to $982M.

Based on GSA Capital Partners's 13F filing for Q3 2021, filed 12 Nov 2021.